Literature DB >> 18806984

[Alternatives to beta blockers in preventive migraine treatment].

S Evers1.   

Abstract

Drug prevention of migraine is recommended if more than three attacks occur per month, acute drug treatment is insufficient, or very severe attacks with aura are the main problem. Besides beta blockers, a variety of substances have proved efficacious in migraine prevention. Thus individualised treatment of migraine patients is possible. When choosing the appropriate preventive drug, the potential side effects are considered. Drugs of first choice, besides beta blockers, are flunarizine, valproic acid, and topiramate. Second-choice drugs with lower efficacy or less well published evidence include amitriptyline, venlafaxine, gabapentin, naproxen, acetylsalicylic acid, butterbur root, vitamin B2, and magnesium. Flunarizine or propranolol are recommended for children.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806984     DOI: 10.1007/s00115-008-2522-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  83 in total

1.  Fluoxetine for migraine prophylaxis: a double-blind trial.

Authors:  C C d'Amato; V Pizza; T Marmolo; E Giordano; V Alfano; A Nasta
Journal:  Headache       Date:  1999 Nov-Dec       Impact factor: 5.887

2.  Lamotrigine versus placebo in the prophylaxis of migraine with and without aura.

Authors:  T J Steiner; L J Findley; A W Yuen
Journal:  Cephalalgia       Date:  1997-04       Impact factor: 6.292

3.  Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.

Authors:  Paul Winner; Astrid Gendolla; Catherine Stayer; Steven Wang; Eric Yuen; Wendy P Battisti; Jeffrey S Nye
Journal:  Headache       Date:  2006 Nov-Dec       Impact factor: 5.887

4.  Selective serotonin reuptake inhibitors for migraine prophylaxis.

Authors:  S Landy; J McGinnis; D Curlin; S C Laizure
Journal:  Headache       Date:  1999-01       Impact factor: 5.887

5.  Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine.

Authors:  T E Whitmarsh; D M Coleston-Shields; T J Steiner
Journal:  Cephalalgia       Date:  1997-08       Impact factor: 6.292

6.  Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects.

Authors:  J R Couch; D K Ziegler; R Hassanein
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

7.  Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.

Authors:  E A MacGregor; A Frith; J Ellis; L Aspinall; A Hackshaw
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

8.  A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.

Authors:  Stephen D Silberstein; Arthur H Elkind; Curtis Schreiber; Charlotte Keywood
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

9.  A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.

Authors:  Frederick G Freitag; S D Collins; H A Carlson; J Goldstein; J Saper; S Silberstein; N Mathew; P K Winner; R Deaton; K Sommerville
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

10.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

View more
  1 in total

Review 1.  [The value of "migraine surgery". Overview of the pathophysiological concept and current evidence].

Authors:  C Gaul; D Holle; P S Sandor; S Evers; G Broessner; A Straube; H-C Diener
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.